Zusammenfassung
Die Inzidenz des Ösophaguskarzinoms ist in Deutschland in den letzten Jahren steigend. Ziel der vorliegenden Arbeit ist die Diskussion der ökonomischen Aspekte der onkologischen Ösophaguschirurgie im deutschen DRG-System mit Fokus auf den Zusammenhang zwischen Mindestmengengrenzen und Ergebnisqualität sowie Kosten. Die Marge der DRG G03A ist gering und wird schnell aufgezehrt, wenn Komplikationen den postoperativen Verlauf bestimmen. Eine aktuelle Analyse der deutschen Krankenhausabrechnungsdaten konnte einen signifikanten Unterschied der Klinikletalität zwischen Kliniken mit und ohne Erreichen der Mindestmengen der Ösophagektomie belegen. US-amerikanische Daten zeigen, dass neben patientenrelevanten Parametern das Fallvolumen des Chirurgen relevant für die Kosten der Behandlung ist. Derartige kostenbezogene Analysen liegen in Deutschland derzeit nicht vor. Zukünftig erstrebenswert ist die wissenschaftliche Validierung belastbarer Mindestmengengrenzen für die onkologische Ösophagusresektion.
Abstract
The incidence of esophageal carcinoma has increased in recent years in Germany. The aim of this article is a discussion of the economic aspects of oncological esophageal surgery within the German diagnosis-related groups (DRG) system focusing on the association between minimum caseload requirements and outcome quality as well as costs. The margins for the DRG classification G03A are low and quickly exhausted if complications determine the postoperative course. A current study using nationwide German hospital discharge data proved a significant difference in hospital mortality between clinics with and without achieving the minimum caseload requirements for esophagectomy. Data from the USA clearly showed that besides patient-relevant parameters, the caseload of a surgeon is relevant for the cost of treatment. Such cost-related analyses do not exist in Germany at present. Scientific validation of reliable minimum caseload numbers for oncological esophagectomy is desirable in the future.
Literatur
Kaatsch P, Spix C, Hentschel S, Katalinic A, Luttermann S, Stegmaier C, Casparitz S, Cernaj J, Ernst A, Folkerts J, Hansmann J, Kranzhöfer K, Krieghoff-Henning E, Kunz B, Penzkofer A, Treml K, Wittenberg K, Baras N, Barnes B, Bertz J, Buttmann-Schweiger N, Dahm S, Franke M, Haberland J, Kraywinkel K, Wienecke A, Wolf U (2014) Cancer in Germany 2009/2010, 9. Aufl. Robert Koch Institute, the Association of Population-based Cancer Registries in Germany, Berlin. ISBN 9783896062239
Brown LM, Devesa SS, Chow WH (2008) Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 100(16):1184–1187
Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P (2011) Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med 365(15):1375–1383
Lordick F, Hölscher A, Haustermans K, Wittekind C (2013) Multimodal treatment of esophageal cancer. Langenbecks Arch Surg 398(2):177–187
Porschen R, Buck A, Fischbach W, Gockel I, Görling U, Grenacher L, Hollerbach S, Hölscher A, Körber J, Messmann H, Meyer HJ, Miehlke A, Möhler M, Nöthlings U, Pech O, Schmidberger H, Schmidt M, Stahl M, Stuschke M, Thuss-Patience P, Trojan J, Vanhoefer U, Weimann A, Wenz F, Wullstein C (2015) S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus (Langversion 1.0 – September 2015, AWMF-Registriernummer: 021/023OL. Z Gastroenterol 53(11):1288–1347
Hsieh CC, Chien CW (2009) A cost and benefit study of esophagectomy for patients with esophageal cancer. J Gastrointest Surg 13(10):1806–1812
Gordon LG, Hirst NG, Mayne GC, Watson DI, Bright T, Cai W, Barbour AP, Smithers BM, Whiteman DC, Eckermann S, Australian Cancer Study Clinical Follow-up Study (2012) Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia. J Gastrointest Surg 16(8):1451–1461
Regelungen des Gemeinsamen Bundesausschusses gemäß § 136b Absatz 1 Satz 1 Nummer 2 SGB V für nach § 108 SGB V zugelassene Krankenhäuser (Mindestmengenregelungen, Mm-R). https://www.g-ba.de/downloads/62-492-1156/Mm-R_2016-03-17_iK-2016-01-01-2016-04-07.pdf accessed. 29. Juli 2017
Gockel I, Ahlbrand CJ, Arras M, Schreiber EM, Lang H (2015) Quality management and key performance indicators in oncologic esophageal surgery. Dig Dis Sci 60(12):3536–3544
Mansky T, Nimptsch U, Schuler E, Zacher J, Cools A, Hellerhoff F (2013) Definitionshandbuch für das Jahr 2013. G‑IQI. German Inpatient Quality Indicators. Version 4.2, Bd. 1. doi:10.14279/depositonce-4610
Murphy CC, Incalcaterra JR, Albright HW, Correa AM, Swisher SG, Hofstetter WL (2013) Pretreatment patient comorbidity and tobacco use increase cost and risk of postoperative complications after esophagectomy at a high-volume cancer center. J Oncol Pract 9(5):233–239
Lagergren J, Andersson G, Talbäck M, Drefahl S, Bihagen E, Härkönen J, Feychting M, Ljung R (2016) Marital status, education, and income in relation to the risk of esophageal and gastric cancer by histologic type and site. Cancer 122(2):207–212
Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346(15):1128–1137
Steyerberg EW, Neville BA, Koppert LB, Lemmens VEPP, Tilanus HW, Coebergh JWW, Weeks JC, Earle CC (2006) Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol 24(26):4277–4284
Carrott PW, Markar SR, Kuppusamy MK, Traverso LW, Low DE (2012) Accordion Severity Grading System: assessment of relationship between costs, length of hospital stay, and survival in patients with complications after esophagectomy for cancer. J Am Coll Surg 215(3):331–336
Stitzenberg KB, Chang YK, Smith AB, Nielsen ME (2015) Exploring the burden of inpatient readmissions after major cancer surgery. J Clin Oncol 33(5):455–464
Markar SR, Karthikesalingam A, Thrumurthy S, Low DE (2012) Volume-outcome relationship in surgery for esophageal malignancy: systematic review and meta-analysis 2000–2011. J Gastrointest Surg 16(5):1055–1063
Wouters MW, Gooiker GA, van Sandick JW, Tollenaar RA (2012) The volume-outcome relation in the surgical treatment of esophageal cancer: a systematic review and meta-analysis. Cancer 118(7):1754–1763
Coupland VH, Lagergren J, Luchtenborg M, Jack RH, Allum W, Holmberg L, Hanna GB, Pearce N, Moller H (2013) Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004–2008. Gut 62(7):961–966
Ghaferi AA, Birkmeyer JD, Dimick JB (2011) Hospital volume and failure to rescue with high-risk surgery. Med Care 49(12):1076–1081
Almoudaris AM, Mamidanna R, Bottle A, Aylin P, Vincent C, Faiz O, Hanna GB (2013) Failure to rescue patients after reintervention in gastroesophageal cancer surgery in England. JAMA Surg 148(3):272–276
Bundesgesetzblatt Jahrgang 2015 Teil I Nr. 51, ausgegeben zu Bonn am 17. Dezember 2015
Metzger R, Bollschweiler E, Vallbohmer D, Maish M, DeMeester TR, Holscher AH (2004) High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus 17(4):310–314
Peschke D, Nimptsch U, Mansky T (2014) Achieving minimum caseload requirements – an analysis of hospital discharge data from 2005–2011. Dtsch Ärztebl Int 111(33–34):556–563
Nimptsch U, Peschke D, Mansky T (2016) Minimum caseload requirements and in-hospital mortality: observational study using nationwide hospital discharge data from 2006 to 2013. Gesundheitswesen. doi:10.1005/s-0042-100731
Munasinghe A, Markar SR, Mamidanna R, Darzi AW, Faiz OD, Hanna GB, Low DE (2015) Is it time to centralize high-risk cancer care in the United States? Comparison of outcomes of esophagectomy between england and the United States. Ann Surg 262:79. doi:10.1097/sla.0000000000000805
Gaitonde SG, Hanseman D, Wima K, Sutton JM, Wilson GC, Sussman JJ, Ahmad SA, Shah SA, Abbott DE (2015) Resource utilization in esophagectomy: When higher costs are associated with worse outcomes. J Surg Oncol 112(1):51–55
van Adrichem EJ, Meulenbroek RL, Plukker JTM, Groen H, van Weert E (2014) Comparison of two preoperative inspiratory muscle training programs to prevent pulmonary complications in patients undergoing esophagectomy: a randomized controlled pilot study. Ann Surg Oncol 21(7):2353–2360
Cao S, Zhao G, Cui J, Dong Q, Qi S, Xin Y, Shen B, Guo Q (2012) Fast-track rehabilitation program and conventional care after esophagectomy: a retrospective controlled cohort study. Support Care Cancer 21(3):707–714
Blom RL, van Heijl M, Bemelman WA, Hollmann MW, Klinkenbijl JHG, Busch ORC, van Berge Henegouwen MI (2013) Initial experiences of an enhanced recovery protocol in esophageal surgery. World J Surg 37(10):2372–2378
Lee L, Li C, Robert N, Latimer E, Carli F, Mulder DS, Fried GM, Ferri LE, Feldman LS (2013) Economic impact of an enhanced recovery pathway for oesophagectomy. Br J Surg 100(10):1326–1334
http://drg.uni-muenster.de/index.php?option=com_webgrouper&view=webgrouper&Itemid=112 accessed 29. Juli 2016
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
N. von Dercks, I. Gockel, M. Mehdorn und D. Lorenz geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
von Dercks, N., Gockel, I., Mehdorn, M. et al. Ökonomische Aspekte der onkologischen Ösophaguschirurgie. Chirurg 88, 62–69 (2017). https://doi.org/10.1007/s00104-016-0326-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00104-016-0326-7
Schlüsselwörter
- Onkologische Ösophagusresektion
- Ökonomische Aspekte
- Mindestmengengrenzen des G‑BA (Gemeinsamer Bundesausschuss)
- Fallzahlvolumen
- Ergebnisqualität – Kosten